These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28636463)

  • 1. Optimization of an anti-HER2 nanobody expression using the Taguchi method.
    Farasat A; Rahbarizadeh F; Ahmadvand D; Yazdian F
    Prep Biochem Biotechnol; 2017 Sep; 47(8):795-803. PubMed ID: 28636463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and Characterization of the Extracellular Domain of Human HER2 from Escherichia Coli, and Production of Polyclonal Antibodies Against the Recombinant Proteins.
    Sun Y; Feng X; Qu J; Han W; Liu Z; Li X; Zou M; Zhen Y; Zhu J
    Appl Biochem Biotechnol; 2015 Jun; 176(4):1029-43. PubMed ID: 25906688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small sized EGFR1 and HER2 specific bifunctional antibody for targeted cancer therapy.
    Ding L; Tian C; Feng S; Fida G; Zhang C; Ma Y; Ai G; Achilefu S; Gu Y
    Theranostics; 2015; 5(4):378-98. PubMed ID: 25699098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer.
    Xavier C; Vaneycken I; D'huyvetter M; Heemskerk J; Keyaerts M; Vincke C; Devoogdt N; Muyldermans S; Lahoutte T; Caveliers V
    J Nucl Med; 2013 May; 54(5):776-84. PubMed ID: 23487015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanobody production can be simplified by direct secretion from Escherichia coli.
    Iwaki T; Hara K; Umemura K
    Protein Expr Purif; 2020 Jun; 170():105607. PubMed ID: 32062022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An efficient protocol towards site-specifically clickable nanobodies in high yield: cytoplasmic expression in Escherichia coli combined with intein-mediated protein ligation.
    Ta DT; Redeker ES; Billen B; Reekmans G; Sikulu J; Noben JP; Guedens W; Adriaensens P
    Protein Eng Des Sel; 2015 Oct; 28(10):351-63. PubMed ID: 26243885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An efficient constitutive expression system for Anti-CEACAM5 nanobody production in the yeast Pichia pastoris.
    Chen Q; Zhou Y; Yu J; Liu W; Li F; Xian M; Nian R; Song H; Feng D
    Protein Expr Purif; 2019 Mar; 155():43-47. PubMed ID: 30414968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma.
    Keyaerts M; Xavier C; Heemskerk J; Devoogdt N; Everaert H; Ackaert C; Vanhoeij M; Duhoux FP; Gevaert T; Simon P; Schallier D; Fontaine C; Vaneycken I; Vanhove C; De Greve J; Lamote J; Caveliers V; Lahoutte T
    J Nucl Med; 2016 Jan; 57(1):27-33. PubMed ID: 26449837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (18)F-nanobody for PET imaging of HER2 overexpressing tumors.
    Xavier C; Blykers A; Vaneycken I; D'Huyvetter M; Heemskerk J; Lahoutte T; Devoogdt N; Caveliers V
    Nucl Med Biol; 2016 Apr; 43(4):247-52. PubMed ID: 27067045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection and characterization of specific nanobody against bovine virus diarrhea virus (BVDV) E2 protein.
    Li T; Huang M; Xiao H; Zhang G; Ding J; Wu P; Zhang H; Sheng J; Chen C
    PLoS One; 2017; 12(6):e0178469. PubMed ID: 28582444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel immuno-gold labeling protocol for nanobody-based detection of HER2 in breast cancer cells using immuno-electron microscopy.
    Kijanka M; van Donselaar EG; Müller WH; Dorresteijn B; Popov-Čeleketić D; El Khattabi M; Verrips CT; van Bergen En Henegouwen PMP; Post JA
    J Struct Biol; 2017 Jul; 199(1):1-11. PubMed ID: 28552722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of the BoNT/A-Hc expression in recombinant Escherichia coli using the Taguchi statistical method.
    Yari K; Fatemi SS; Tavallaei M
    Biotechnol Appl Biochem; 2010 May; 56(1):35-42. PubMed ID: 20412050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel nanobody against urease activity of Helicobacter pylori.
    Ardekani LS; Gargari SL; Rasooli I; Bazl MR; Mohammadi M; Ebrahimizadeh W; Bakherad H; Zare H
    Int J Infect Dis; 2013 Sep; 17(9):e723-8. PubMed ID: 23561799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of temperature on the production of a recombinant antivenom in fed-batch mode.
    Alonso Villela SM; Ghezal-Kraïem H; Bouhaouala-Zahar B; Bideaux C; Aceves Lara CA; Fillaudeau L
    Appl Microbiol Biotechnol; 2021 Feb; 105(3):1017-1030. PubMed ID: 33443635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A camelid nanobody against EGFR was easily obtained through refolding of inclusion body expressed in Escherichia coli.
    Xu L; Song X; Jia L
    Biotechnol Appl Biochem; 2017 Nov; 64(6):895-901. PubMed ID: 28853185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant λ bacteriophage displaying nanobody towards third domain of HER-2 epitope inhibits proliferation of breast carcinoma SKBR-3 cell line.
    Shoae-Hassani A; Mortazavi-Tabatabaei SA; Sharif S; Madadi S; Rezaei-Khaligh H; Verdi J
    Arch Immunol Ther Exp (Warsz); 2013 Feb; 61(1):75-83. PubMed ID: 23224340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-expression of monoclonal nanobodies used in the preparation of HRP-conjugated second antibody.
    Ahmadvand D; Rahbarizadeh F; Vishteh VK
    Hybridoma (Larchmt); 2008 Aug; 27(4):269-76. PubMed ID: 18707545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cells expressing VHH-directed oligoclonal chimeric HER2 antigen receptors: towards tumor-directed oligoclonal T cell therapy.
    Jamnani FR; Rahbarizadeh F; Shokrgozar MA; Mahboudi F; Ahmadvand D; Sharifzadeh Z; Parhamifar L; Moghimi SM
    Biochim Biophys Acta; 2014 Jan; 1840(1):378-86. PubMed ID: 24076235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered cross-reacting nanobodies simplify comparative oncology between humans and dogs.
    Mazzega E; de Marco A
    Vet Comp Oncol; 2018 Mar; 16(1):E202-E206. PubMed ID: 29047203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An optimized protocol for overproduction of recombinant protein expression in Escherichia coli.
    Bahreini E; Aghaiypour K; Abbasalipourkabir R; Goodarzi MT; Saidijam M; Safavieh SS
    Prep Biochem Biotechnol; 2014; 44(5):510-28. PubMed ID: 24219068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.